Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Unity Biotechnology, Inc. | 150,000 | reported | 06 Jan 2025 | tx 1+150,000 |
| Apellis Pharmaceuticals, Inc. | 94,884 | reported | 05 Jan 2023 | tx 89+577,969−148,135 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Jan 2025 | GRANT_AWARD | Unity Biotechnology, Inc. | 150,000 | 0.00 USD | deriv |
| 05 Jan 2023 | SALE | Apellis Pharmaceuticals, Inc. | 2,500 | 48.79 USD | |
| 01 Dec 2022 | SALE | Apellis Pharmaceuticals, Inc. | 2,500 | 49.93 USD | |
| 01 Nov 2022 | SALE | Apellis Pharmaceuticals, Inc. | 2,500 | 60.83 USD | |
| 03 Oct 2022 | SALE | Apellis Pharmaceuticals, Inc. | 2,500 | 66.69 USD | anomaly |
| 01 Sept 2022 | SALE | Apellis Pharmaceuticals, Inc. | 2,500 | 60.30 USD | |
| 01 Aug 2022 | SALE | Apellis Pharmaceuticals, Inc. | 2,500 | 55.99 USD | |
| 01 Jun 2022 | SALE | Apellis Pharmaceuticals, Inc. | 2,500 | 41.78 USD | |
| 21 Apr 2022 | OTHER | Apellis Pharmaceuticals, Inc. | 1,875 | 0.00 USD | |
| 02 May 2022 | SALE | Apellis Pharmaceuticals, Inc. | 2,500 | 43.56 USD | |
| 21 Apr 2022 | OTHER | Apellis Pharmaceuticals, Inc. | 11,250 | 0.00 USD | deriv |
| 15 Mar 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 7,000 | 4.31 USD | |
| 15 Mar 2022 | SALE | Apellis Pharmaceuticals, Inc. | 375 | 39.57 USD | |
| 15 Mar 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 7,000 | 0.00 USD | deriv |
| 01 Mar 2022 | SALE | Apellis Pharmaceuticals, Inc. | 375 | 43.53 USD | |
| 23 Feb 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 4,100 | 4.31 USD | |
| 23 Feb 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 4,100 | 0.00 USD | deriv |
| 15 Feb 2022 | SALE | Apellis Pharmaceuticals, Inc. | 375 | 45.43 USD | |
| 14 Feb 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 3,600 | 4.31 USD | |
| 14 Feb 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 3,600 | 0.00 USD | deriv |
| 10 Feb 2022 | TAX_WITHHOLDING | Apellis Pharmaceuticals, Inc. | 705 | 47.12 USD | |
| 01 Feb 2022 | SALE | Apellis Pharmaceuticals, Inc. | 375 | 40.58 USD | |
| 28 Jan 2022 | TAX_WITHHOLDING | Apellis Pharmaceuticals, Inc. | 650 | 38.59 USD | |
| 21 Jan 2022 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 26,051 | 0.00 USD | |
| 21 Jan 2022 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 36,951 | 0.00 USD | deriv |